Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Accounts Payables (2021 - 2025)

Historic Accounts Payables for Universe Pharmaceuticals (UPC) over the last 5 years, with Q3 2025 value amounting to -$3.1 billion.

  • Universe Pharmaceuticals' Accounts Payables fell 227931.85% to -$3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 billion, marking a year-over-year decrease of 227931.85%. This contributed to the annual value of -$3.1 billion for FY2025, which is 227931.85% down from last year.
  • As of Q3 2025, Universe Pharmaceuticals' Accounts Payables stood at -$3.1 billion, which was down 227931.85% from $143.7 million recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Accounts Payables registered a high of $1.6 billion during Q3 2023, and its lowest value of -$3.1 billion during Q3 2025.
  • In the last 5 years, Universe Pharmaceuticals' Accounts Payables had a median value of $5.3 million in 2021 and averaged -$267.8 million.
  • In the last 5 years, Universe Pharmaceuticals' Accounts Payables surged by 5327288.6% in 2023 and then plummeted by 227931.85% in 2025.
  • Universe Pharmaceuticals' Accounts Payables (Quarter) stood at $5.3 million in 2021, then plummeted by 42.09% to $3.1 million in 2022, then surged by 53272.89% to $1.6 billion in 2023, then plummeted by 91.24% to $143.7 million in 2024, then crashed by 2279.32% to -$3.1 billion in 2025.
  • Its Accounts Payables was -$3.1 billion in Q3 2025, compared to $143.7 million in Q3 2024 and $1.6 billion in Q3 2023.